<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD10920000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P08588</UniProt_ID>
  <Seq_Length>477</Seq_Length>
  <Molecule_Weight>51323</Molecule_Weight>
  <KEGG_ID>hsa:153</KEGG_ID>
  <Orthology_ID>K04141</Orthology_ID>
  <EBI_ID>EBI-991009</EBI_ID>
  <Function_Summary>Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. This receptor binds epinephrine and norepinephrine with approximately equal affinity. Mediates Ras activation through G(s)-alpha- and cAMP-mediated signaling.</Function_Summary>
  <Pfam_ID>PF00001:7tm_1</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Beta-1 adrenoreceptor</Alias>
      <Alias>Beta-1 adrenoceptor</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Combining with an extracellular or intracellular messenger to initiate a change in cell activity.</Detail>
      <Keyword>Receptor activity</Keyword>
      <Ontology_ID>GO:0004872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Conveys a signal from an upstream receptor or intracellular signal transducer, converting the signal into a form where it can ultimately trigger a change in the state or activity of a cell.</Detail>
      <Keyword>Receptor signaling protein activity</Keyword>
      <Ontology_ID>GO:0005057</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with dopamine, a catecholamine neurotransmitter formed by aromatic-L-amino-acid decarboxylase from 3,4-dihydroxy-L-phenylalanine.</Detail>
      <Keyword>Dopamine binding</Keyword>
      <Ontology_ID>GO:0035240</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with epinephrine, a hormone produced by the medulla of the adrenal glands that increases heart activity, improves the power and prolongs the action of muscles, and increases the rate and depth of breathing. It is synthesized by the methylation of norepinephrine.</Detail>
      <Keyword>Epinephrine binding</Keyword>
      <Ontology_ID>GO:0051379</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with norepinephrine, (3,4-dihydroxyphenyl-2-aminoethanol), a hormone secreted by the adrenal medulla and a neurotransmitter in the sympathetic peripheral nervous system and in some tracts of the CNS. It is also the biosynthetic precursor of epinephrine.</Detail>
      <Keyword>Norepinephrine binding</Keyword>
      <Ontology_ID>GO:0051380</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ras superfamily. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.</Detail>
      <Keyword>Ras guanyl-nucleotide exchange factor activity</Keyword>
      <Ontology_ID>GO:0005088</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of beta1-adrenergic receptors.</Detail>
      <Keyword>Beta1-adrenergic receptor activity</Keyword>
      <Ontology_ID>GO:0004940</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.</Detail>
      <Keyword>Drug binding</Keyword>
      <Ontology_ID>GO:0008144</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>26</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>399</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>31</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>29</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>389</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>49</Position>
      <Original>Ser</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>389</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>405</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle contraction.</Detail>
      <Keyword>Negative regulation of smooth muscle contraction</Keyword>
      <Ontology_ID>GO:0045986</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process which activates, maintains or increases the frequency, rate or extent of cAMP-mediated signaling, a series of molecular signals in which a cell uses cyclic AMP to convert an extracellular signal into a response.</Detail>
      <Keyword>Positive regulation of cAMP-mediated signaling</Keyword>
      <Ontology_ID>GO:0043950</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process in which a protein is transported to, or maintained in, a location within an organelle.</Detail>
      <Keyword>Protein localization to organelle</Keyword>
      <Ontology_ID>GO:0033365</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of molecular signals within the cell that are mediated by a member of the Rho family of proteins switching to a GTP-bound active state.</Detail>
      <Keyword>Rho protein signal transduction</Keyword>
      <Ontology_ID>GO:0007266</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the directed movement of calcium ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Regulation of calcium ion transport</Keyword>
      <Ontology_ID>GO:0051924</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which a relatively unspecialized cell acquires specialized features of a brown adipocyte, an animal connective tissue cell involved in adaptive thermogenesis. Brown adipocytes contain multiple small droplets of triglycerides and a high number of mitochondria.</Detail>
      <Keyword>Brown fat cell differentiation</Keyword>
      <Ontology_ID>GO:0050873</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the establishment or extent of the inhibitory postsynaptic potential (IPSP) which is a temporay decrease in postsynaptic potential due to the flow of negatively charged ions into the postsynaptic cell. The flow of ions that causes an IPSP is an inhibitory postsynaptic current (IPSC) and makes it more difficult for the neuron to fire an action potential.</Detail>
      <Keyword>Regulation of inhibitory postsynaptic membrane potential</Keyword>
      <Ontology_ID>GO:0060080</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process that results in an increase in the diameter of an artery during the norepinephrine-epinephrine response to blood pressure change.</Detail>
      <Keyword>Vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure</Keyword>
      <Ontology_ID>GO:0002025</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the rate, frequency, or extent of the growth of a cardiac muscle cell, where growth contributes to the progression of the cell over time from its initial formation to its mature state.</Detail>
      <Keyword>Positive regulation of cell growth involved in cardiac muscle cell development</Keyword>
      <Ontology_ID>GO:0061051</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which the presence of epinephrine or norepinephrine in the bloodstream activates, maintains or increases the rate of heart contraction.</Detail>
      <Keyword>Positive regulation of heart rate by epinephrine-norepinephrine</Keyword>
      <Ontology_ID>GO:0001996</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of growth of an organism to reach its usual body size.</Detail>
      <Keyword>Negative regulation of multicellular organism growth</Keyword>
      <Ontology_ID>GO:0040015</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The response of an organism to a perceived external threat.</Detail>
      <Keyword>Fear response</Keyword>
      <Ontology_ID>GO:0042596</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal, e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light, and ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell, and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.</Detail>
      <Keyword>Signal transduction</Keyword>
      <Ontology_ID>GO:0007165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process involved in the maintenance of an internal steady state of lipid within an organism or cell.</Detail>
      <Keyword>Lipid homeostasis</Keyword>
      <Ontology_ID>GO:0055088</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A form of programmed cell death that begins when a cell receives internal or external signals that trigger the activity of proteolytic caspases, proceeds through a series of characteristic stages typically including rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), and plasma membrane blebbing (but maintenance of its integrity until the final stages of the process), and ends with the death of the cell.</Detail>
      <Keyword>Apoptosis</Keyword>
      <Ontology_ID>GO:0006915</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process that results in increased metabolic rate in tissues of an organism. It is triggered by the detection of dietary excess. This process is achieved via signalling in the sympathetic nervous system.</Detail>
      <Keyword>Diet induced thermogenesis</Keyword>
      <Ontology_ID>GO:0002024</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the breakdown of glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues.</Detail>
      <Keyword>Glycogen catabolic process</Keyword>
      <Ontology_ID>GO:0005980</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of an adrenergic receptor binding to its physiological ligand, followed by activation of adenylyl cyclase and a subsequent increase in the concentration of cyclic AMP.</Detail>
      <Keyword>Activation of adenylate cyclase activity by adrenergic receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0071880</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that initiates the activity of the inactive enzyme adenylate cyclase.</Detail>
      <Keyword>Activation of adenylate cyclase activity</Keyword>
      <Ontology_ID>GO:0007190</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any homeostatic process in which an organism produces heat, thereby raising its internal temperature.</Detail>
      <Keyword>Heat generation</Keyword>
      <Ontology_ID>GO:0031649</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process that increases the force with which blood travels through the systemic arterial circulatory system.</Detail>
      <Keyword>Positive regulation of systemic arterial blood pressure</Keyword>
      <Ontology_ID>GO:0003084</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cold stimulus, a temperature stimulus below the optimal temperature for that organism.</Detail>
      <Keyword>Response to cold</Keyword>
      <Ontology_ID>GO:0009409</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the regulated release of saliva.</Detail>
      <Keyword>Positive regulation of saliva secretion</Keyword>
      <Ontology_ID>GO:0046878</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The inherent decline over time, from the optimal fertility and viability of early maturity, that may precede death and may be preceded by other indications, such as sterility.</Detail>
      <Keyword>Aging</Keyword>
      <Ontology_ID>GO:0007568</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the activity of a GTPase of the Ras superfamily.</Detail>
      <Keyword>Positive regulation of Ras GTPase activity</Keyword>
      <Ontology_ID>GO:0032320</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The activities involved in the mental information processing system that receives (registers), modifies, stores, and retrieves informational stimuli. The main stages involved in the formation and retrieval of memory are encoding (processing of received information by acquisition), storage (building a permanent record of received information as a result of consolidation) and retrieval (calling back the stored information and use it in a suitable way to execute a given task).</Detail>
      <Keyword>Memory</Keyword>
      <Ontology_ID>GO:0007613</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of events required for an organism to receive a painful stimulus, convert it to a molecular signal, and recognize and characterize the signal. Pain is medically defined as the physical sensation of discomfort or distress caused by injury or illness, so can hence be described as a harmful stimulus which signals current (or impending) tissue damage. Pain may come from extremes of temperature, mechanical damage, electricity or from noxious chemical substances. This is a neurological process.</Detail>
      <Keyword>Sensory perception of pain</Keyword>
      <Ontology_ID>GO:0019233</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.</Detail>
      <Keyword>G-protein coupled receptor protein signaling pathway</Keyword>
      <Ontology_ID>GO:0007186</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of events that restore integrity to a damaged tissue, following an injury.</Detail>
      <Keyword>Wound healing</Keyword>
      <Ontology_ID>GO:0042060</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which the secretion of norepinephrine into the bloodstream or released from nerve endings modulates the force of heart musclecontraction.</Detail>
      <Keyword>Positive regulation of the force of heart contraction by norepinephrine</Keyword>
      <Ontology_ID>GO:0003061</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>312</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>412</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MGAGVLVLGASEPGNLSSAAPLPDGAATAARLLVPASPPASLLPPASESPEPLSQQWTAGMGLLMALIVLLIVAGNVLVIVAIAKTPRLQTLTNLFIMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPFRYQSLLTRARARGLVCTVWAISALVSFLPILMHWWRAESDEARRCYNDPKCCDFVTNRAYAIASSVVSFYVPLCIMAFVYLRVFREAQKQVKKIDSCERRFLGGPARPPSPSPSPVPAPAPPPGPPRPAAAAATAPLANGRAGKRRPSRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRELVPDRLFVFFNWLGYANSAFNPIIYCRSPDFRKAFQRLLCCARRAARRRHATHGDRPRASGCLARPGPPPSPGAASDDDDDDVVGATPPARLLEPWAGCNGGAAADSDSSLDEPCRPGFASESKV</Protein_Seq>
    <DNA_Seq>GCACCACGCCGCCCGGGCTTCTGGGGTGTTCCCCAACCACGGCCCAGCCCTGCCACACCCCCCGCCCCCGGCCTCCGCAGCTCGGCATGGGCGCGGGGGTGCTCGTCCTGGGCGCCTCCGAGCCCGGTAACCTGTCGTCGGCCGCACCGCTCCCCGACGGCGCGGCCACCGCGGCGCGGCTGCTGGTGCCCGCGTCGCCGCCCGCCTCGTTGCTGCCTCCCGCCAGCGAAAGCCCCGAGCCGCTGTCTCAGCAGTGGACAGCGGGCATGGGTCTGCTGATGGCGCTCATCGTGCTGCTCATCGTGGCGGGCAATGTGCTGGTGATCGTGGCCATCGCCAAGACGCCGCGGCTGCAGACGCTCACCAACCTCTTCATCATGTCCCTGGCCAGCGCCGACCTGGTCATGGGGCTGCTGGTGGTGCCGTTCGGGGCCACCATCGTGGTGTGGGGCCGCTGGGAGTACGGCTCCTTCTTCTGCGAGCTGTGGACCTCAGTGGACGTGCTGTGCGTGACGGCCAGCATCGAGACCCTGTGTGTCATTGCCCTGGACCGCTACCTCGCCATCACCTCGCCCTTCCGCTACCAGAGCCTGCTGACGCGCGCGCGGGCGCGGGGCCTCGTGTGCACCGTGTGGGCCATCTCGGCCCTGGTGTCCTTCCTGCCCATCCTCATGCACTGGTGGCGGGCGGAGAGCGACGAGGCGCGCCGCTGCTACAACGACCCCAAGTGCTGCGACTTCGTCACCAACCGGGCCTACGCCATCGCCTCGTCCGTAGTCTCCTTCTACGTGCCCCTGTGCATCATGGCCTTCGTGTACCTGCGGGTGTTCCGCGAGGCCCAGAAGCAGGTGAAGAAGATCGACAGCTGCGAGCGCCGTTTCCTCGGCGGCCCAGCGCGGCCGCCCTCGCCCTCGCCCTCGCCCGTCCCCGCGCCCGCGCCGCCGCCCGGACCCCCGCGCCCCGCCGCCGCCGCCGCCACCGCCCCGCTGGCCAACGGGCGTGCGGGTAAGCGGCGGCCCTCGCGCCTCGTGGCCCTGCGCGAGCAGAAGGCGCTCAAGACGCTGGGCATCATCATGGGCGTCTTCACGCTCTGCTGGCTGCCCTTCTTCCTGGCCAACGTGGTGAAGGCCTTCCACCGCGAGCTGGTGCCCGACCGCCTCTTCGTCTTCTTCAACTGGCTGGGCTACGCCAACTCGGCCTTCAACCCCATCATCTACTGCCGCAGCCCCGACTTCCGCAAGGCCTTCCAGGGACTGCTCTGCTGCGCGCGCAGGGCTGCCCGCCGGCGCCACGCGACCCACGGAGACCGGCCGCGCGCCTCGGGCTGTCTGGCCCGGCCCGGACCCCCGCCATCGCCCGGGGCCGCCTCGGACGACGACGACGACGATGTCGTCGGGGCCACGCCGCCCGCGCGCCTGCTGGAGCCCTGGGCCGGCTGCAACGGCGGGGCGGCGGCGGACAGCGACTCGAGCCTGGACGAGCCGTGCCGCCCCGGCTTCGCCTCGGAATCCAAGGTGTAGGGCCCGGCGCGGGGCGCGGACTCCGGGCACGGCTTCCCAGGGGAACGAGGAGATCTGTGTTTACTTAAGACCGATAGCAGGTGAACTCGAAGCCCACAATCCTCGTCTGAATCATCCGAGGCAAAGAGAAAAGCCACGGACCGTTGCACAAAAAGGAAAGTTTGGGAAGGGATGGGAGAGTGGCTTGCTGATGTTCCTTGTTGTTTTTTTTTTCTTTTCTTTTCTTTCTTCTTCTTTTTTTTTTTTTTTTTTTTTTCTGTTTGTGGTCCGGCCTTCTTTTGTGTGTGCGTGTGATGCATCTTTAGATTTTTTTCCCCCACCAGGTGGTTTTTGACACTCTCTGAGAGGACCGGAGTGGAAGATGGGTGGGTTAGGGGAAGGGAGAAGCATTAGGAGGGGATTAAAATCGATCATCGTGGCTCCCATCCCTTTCCCGGGAACAGGAACACACTACCAGCCAGAGAGAGGAGAATGACAGTTTGTCAAGACATATTTCCTTTTGCTTTCCAGAGAAATTTCATTTTAATTTCTAAGTAATGATTTCTGCTGTTATGAAAGCAAAGAGAAAGGATGGAGGCAAAATAAAAAAAAATCACGTTTCAAGAAATGTTAAGCTCTTCTTGGAACAAGCCCCACCTTGCTTTCCTTGTGTAGGGCAAACCCGCTGTCCCCCGCGCGCCTGGGTGGTCAGGCTGAGGGATTTCTACCTCACACTGTGCATTTGCACAGCAGATAGAAAGACTTGTTTATATTAAACAGCTTATTTATGTATCAATATTAGTTGGAAGGACCAGGCGCAGAGCCTCTCTCTGTGACATGTGACTCTGTCAATTGAAGACAGGACATTAAAAGAGAGCGAGAGAGAGAAACAGTTCAGATTACTGCACATGTGGATAAAAACAAAAACAAAAAAAAGGAGTGGTTCAAAATGCCATTTTTGCACAGTGTTAGGAATTACAAAATCCACAGAAGATGTTACTTGCACAAAAAGAAATTAAATATTTTTTAAAGGGAGAGGGGCTGGGCAGATCTTAAATAAAATTCAAACTCTACTTCTGTTGTCTAGTATGTTATTGAGCTAATGATTCATTGGGAAAATACCTTTTTATACTCCTTTATCATGGTACTGTAACTGTATCCATATTATAAATATAATTATCTTAAGGATTTTTTATTTTTTTTTATGTCCAAGTGCCCACGTGAATTTGCTGGTGAAAGTTAGCACTTGTGTGTAAATTCTACTTCCTCTTGTGTGTTTTACCAAGTATTTATACTCTGGTGCAACTAACTACTGTGTGAGGAATTGGTCCATGTGCAATAAATACCAATGAAGCACAATCAA</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
      <Ontology_ID>GO:0005634</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to plasma membrane</CellLocal>
      <Ontology_ID>GO:0005887</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Early endosome</CellLocal>
      <Ontology_ID>GO:0005769</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to membrane</CellLocal>
      <Ontology_ID>GO:0016021</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>ADRB1</Gene_Name>
    <Gene_Alias>ADRB1R; B1AR</Gene_Alias>
    <Gene_ID>153</Gene_ID>
    <Genbank_ACCN>NM_000684</Genbank_ACCN>
    <Protein_ACCN>NP_000675</Protein_ACCN>
    <HGNC_ID>285</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/153</Gene_URL>
    <UCSC_ID>uc001lba.3</UCSC_ID>
    <EMBL_ID>ENSG00000043591</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P14270</Uniprot_ID>
      <Gene_Name>Pde4d</Gene_Name>
      <EBI_ID>EBI-8333209</EBI_ID>
      <PPI_EBI_URL>EBI-991009,EBI-8333209</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q5TCQ9</Uniprot_ID>
      <Gene_Name>MAGI3</Gene_Name>
      <EBI_ID>EBI-310506</EBI_ID>
      <PPI_EBI_URL>EBI-991009,EBI-310506</PPI_EBI_URL>
      <Experiment_Number>5</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q86UL8</Uniprot_ID>
      <Gene_Name>MAGI2</Gene_Name>
      <EBI_ID>EBI-311035</EBI_ID>
      <PPI_EBI_URL>EBI-991009,EBI-311035</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Chagas Disease</Disease_Name>
      <Disease_Detail>Chagas Disease</Disease_Detail>
      <Disease_DB>CHG001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/chagas_disease?search=ADRB1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Endomyocardial Fibrosis</Disease_Name>
      <Disease_Detail>Endomyocardial Fibrosis</Disease_Detail>
      <Disease_DB>END021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/endomyocardial_fibrosis?search=ADRB1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Myocarditis</Disease_Name>
      <Disease_Detail>Myocarditis</Disease_Detail>
      <Disease_DB>MYC008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/myocarditis?search=ADRB1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Congestive Heart Failure</Disease_Name>
      <Disease_Detail>Congestive Heart Failure</Disease_Detail>
      <Disease_DB>CNG034</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/congestive_heart_failure?search=ADRB1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Morbid Obesity</Disease_Name>
      <Disease_Detail>Morbid Obesity</Disease_Detail>
      <Disease_DB>MRB003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/morbid_obesity?search=ADRB1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Myocardial Infarction</Disease_Name>
      <Disease_Detail>Myocardial Infarction</Disease_Detail>
      <Disease_DB>MYC007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/myocardial_infarction?search=ADRB1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Meningococcal Infection</Disease_Name>
      <Disease_Detail>Meningococcal Infection</Disease_Detail>
      <Disease_DB>MNN020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/meningococcal_infection?search=ADRB1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Neuroepithelioma</Disease_Name>
      <Disease_Detail>Neuroepithelioma</Disease_Detail>
      <Disease_DB>NRP002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/neuroepithelioma?search=ADRB1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Syncope</Disease_Name>
      <Disease_Detail>Syncope</Disease_Detail>
      <Disease_DB>SYN036</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/syncope?search=ADRB1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Dilated Cardiomyopathy</Disease_Name>
      <Disease_Detail>Dilated Cardiomyopathy</Disease_Detail>
      <Disease_DB>DLT002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/dilated_cardiomyopathy?search=ADRB1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Obesity</Disease_Name>
      <Disease_Detail>Obesity</Disease_Detail>
      <Disease_DB>OBS005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/obesity?search=ADRB1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Congestive Heart Failure and Beta-Blocker Response, Modifier of</Disease_Name>
      <Disease_Detail>Congestive Heart Failure and Beta-Blocker Response, Modifier of</Disease_Detail>
      <Disease_DB>CNG173</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/congestive_heart_failure_and_beta_blocker_response_modifier_of?search=ADRB1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Aortic Coarctation</Disease_Name>
      <Disease_Detail>Aortic Disease</Disease_Detail>
      <Disease_DB>ART031</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/aortic_coarctation?search=ADRB1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Essential Hypertension</Disease_Name>
      <Disease_Detail>Essential Hypertension</Disease_Detail>
      <Disease_DB>ESS002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/essential_hypertension?search=ADRB1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Orthostatic Intolerance</Disease_Name>
      <Disease_Detail>Orthostatic Intolerance</Disease_Detail>
      <Disease_DB>ORT004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/orthostatic_intolerance?search=ADRB1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Obstructive Sleep Apnea</Disease_Name>
      <Disease_Detail>Obstructive Sleep Apnea</Disease_Detail>
      <Disease_DB>OBS061</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/obstructive_sleep_apnea?search=ADRB1#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Analog of the fragment 197-221 of beta-1 adrenoreceptor</PDB_Title>
      <PDB_ID>2LSQ</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2LSQ</PDB_URL>
      <PubMed_Title>Analog of the fragment 197-221 of 1-adrenoreceptor</PubMed_Title>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04540</Pathway_ID>
      <Pathway_Title>Gap junction</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cellular commiunity</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05414</Pathway_ID>
      <Pathway_Title>Dilated cardiomyopathy</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cardiovascular diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04261</Pathway_ID>
      <Pathway_Title>Adrenergic signaling in cardiomyocytes</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Circulatory system</Pathway_Subclass>
    </Network>
  </Network_List>
  <Create_Date>2013-11-12</Create_Date>
</Organism_Record>